The Development of Diagnosis and Prognosis Predictive Model for Peripheral Nerve Disease
1 other identifier
observational
10,000
1 country
1
Brief Summary
This is a retrospective observational cohort study (MRN-PND), aiming to explore the utility of contrast-enhanced MRN (ceMRN) compared to plain MRN in diagnosing peripheral nerve diseases and predicting the prognosis of patients with these conditions. Additionally, artificial intelligence (AI) methods are employed to enhance the diagnostic accuracy of MRN for peripheral nerve diseases and to precisely predict disease outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 12, 2025
CompletedFirst Posted
Study publicly available on registry
February 25, 2025
CompletedFebruary 25, 2025
February 1, 2025
10 years
February 12, 2025
February 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation analysis of MR information and diagnosis outcome
The indicator is the area under the curve of the predict diagnosis outcome.
0.5 year
Study Arms (2)
Healthy Volunteers
Patients with Peripheral Nerve Disease
Eligibility Criteria
Healthy People and Patients with Peripheral Nerve Disease
You may qualify if:
- Patients who underwent MRN scanning at Wuhan Union Hospital between January 2015 and January 2025;
- Age \> 18 years;
- Definitive clinical diagnosis (either healthy individuals or patients with a specific condition).
You may not qualify if:
- Poor quality of imaging;
- Incomplete clinical data or loss to follow-up;
- Unclear clinical diagnosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technologylead
- Wuhan No.1 Hospitalcollaborator
- University Hospital Heidelbergcollaborator
- West China Hospitalcollaborator
Study Sites (1)
Union Hospital,Tongji Medical College,Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2025
First Posted
February 25, 2025
Study Start
January 1, 2015
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
February 25, 2025
Record last verified: 2025-02